ACCD: Accolade, Inc.
About
Accolade, Inc. engages in the provision of technology-enabled health and benefits solutions. The company was founded by Thomas K. Spann and J. Michael Cline in January 2007 and is headquartered in Seattle, WA.
Current Value
$3.471 Year Return
Current Value
$3.471 Year Return
Key Details
Market Cap
$281.07M
P/E Ratio
-3.4
1Y Stock Return
-55.71%
1Y Revenue Growth
16.04%
Dividend Yield
0.00%
Price to Book
0.7
Strategies that include ACCD
Stock's related to ACCD
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NKE | 46.44% | $110.02B | -30.63% | 2.01% |
| ACET | 44.03% | $84.87M | -10.43% | 0.00% |
| KRUS | 37.29% | $1.03B | +38.71% | 0.00% |
| JNPR | 36.98% | $11.61B | +30.55% | 2.49% |
| HCA | 36.97% | $84.88B | +34.82% | 0.77% |
| AMWL | 36.67% | $121.95M | -67.11% | 0.00% |
| XMTR | 36.05% | $1.48B | +50.13% | 0.00% |
| XPER | 35.55% | $378.82M | -19.06% | 0.00% |
| LASR | 32.91% | $526.43M | -2.60% | 0.00% |
| CRBU | 32.83% | $180.20M | -62.45% | 0.00% |
| AMN | 32.37% | $953.75M | -62.61% | 0.00% |
| CERS | 31.93% | $312.00M | -0.59% | 0.00% |
| ATOM | 31.47% | $160.01M | -20.00% | 0.00% |
| AAOI | 31.14% | $1.29B | +114.18% | 0.00% |
| MCFT | 30.78% | $344.65M | -0.29% | 0.00% |
| SFIX | 30.77% | $480.74M | +11.14% | 0.00% |
| CTLT | 30.71% | $10.69B | +47.79% | 0.00% |
| OFIX | 30.70% | $715.75M | +67.38% | 0.00% |
| MPW | 29.41% | $2.60B | -4.63% | 12.59% |
| RMAX | 29.14% | $215.33M | +23.09% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| LPTX | -0.03% | $103.46M | +10.66% | 0.00% |
| JRVR | -0.03% | $168.34M | -52.25% | 4.52% |
| FINV | -0.04% | $909.61M | +27.93% | 3.80% |
| RSG | -0.07% | $66.05B | +31.79% | 1.04% |
| HUM | 0.08% | $33.45B | -45.22% | 1.25% |
| MMC | 0.09% | $108.41B | +10.89% | 1.37% |
| NMAI | 0.16% | - | - | 13.12% |
| ORKA | -0.19% | $780.47M | +82.82% | 0.00% |
| NGL | -0.22% | $572.94M | +5.60% | 0.00% |
| BYRN | 0.26% | $479.70M | +295.19% | 0.00% |
| AWH | -0.28% | $11.44M | -76.87% | 0.00% |
| AOMR | -0.29% | $220.30M | -5.07% | 17.13% |
| CMBT | 0.34% | $2.46B | -29.63% | 13.05% |
| MFIN | 0.35% | - | - | 4.31% |
| DKL | 0.36% | $2.03B | -18.84% | 10.94% |
| COR | -0.36% | $47.48B | +21.20% | 0.86% |
| DLNG | -0.38% | $161.93M | +73.23% | 0.00% |
| ATEX | 0.45% | $617.94M | +5.94% | 0.00% |
| TEO | -0.52% | $1.69B | +87.97% | 0.00% |
| CTMX | 0.65% | $69.86M | -31.59% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NNE | -19.90% | $833.66M | +531.50% | 0.00% |
| CME | -14.71% | $82.76B | +9.21% | 1.98% |
| QTTB | -9.44% | $354.34M | +188.64% | 0.00% |
| OCX | -9.13% | $42.93M | -36.09% | 0.00% |
| CBOE | -8.19% | $21.46B | +15.84% | 1.11% |
| GRFS | -8.15% | $2.18B | -11.41% | 0.00% |
| ACGL | -7.88% | $36.00B | +16.84% | 0.00% |
| DOGZ | -6.88% | $614.77M | +1,372.26% | 0.00% |
| LITB | -6.18% | $35.48M | -75.45% | 0.00% |
| SOLV | -5.62% | $11.58B | -16.19% | 0.00% |
| PRPO | -5.56% | $9.10M | -13.65% | 0.00% |
| MCK | -5.37% | $78.15B | +35.51% | 0.42% |
| SYPR | -4.75% | $32.23M | -26.32% | 0.00% |
| PGR | -4.67% | $149.10B | +57.29% | 0.45% |
| STG | -4.56% | $35.67M | +7.92% | 0.00% |
| NEUE | -4.20% | $40.93M | -34.13% | 0.00% |
| MNOV | -3.99% | $93.19M | +2.15% | 0.00% |
| SNCR | -3.93% | $97.34M | +78.17% | 0.00% |
| CNA | -3.87% | $13.16B | +23.03% | 3.61% |
| KNOP | -3.74% | $210.40M | +11.75% | 1.68% |
ETF's related to ACCD
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -36.76% | $388.04M | 1.43% |
| VIXY | -20.43% | $195.31M | 0.85% |
| UUP | -17.82% | $309.25M | 0.77% |
| USDU | -14.70% | $201.97M | 0.5% |
| KMLM | -10.36% | $353.87M | 0.9% |
| IBHD | -10.29% | $327.80M | 0.35% |
| AGZD | -9.28% | $142.76M | 0.23% |
| SGOV | -8.84% | $27.53B | 0.09% |
| BOXX | -7.38% | $4.43B | 0.1949% |
| CTA | -7.35% | $350.27M | 0.78% |
| BILZ | -7.26% | $563.02M | 0.14% |
| EQLS | -7.17% | $76.08M | 1% |
| TAIL | -6.95% | $67.98M | 0.59% |
| TBIL | -6.92% | $4.38B | 0.15% |
| FLRN | -5.95% | $2.33B | 0.15% |
| SHV | -5.93% | $18.13B | 0.15% |
| KCCA | -5.09% | $220.51M | 0.87% |
| JUCY | -3.82% | $324.29M | 0.6% |
| MINT | -3.75% | $11.62B | 0.35% |
| XBIL | -3.17% | $637.70M | 0.15% |
News
Yahoo
SEATTLE, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor events. A webcast will be available at ir.accolade.com and a replay will be available for 90 days. Stephens Annual Investment Conference | NASH2024 in Nashville on Wednesday, November 20 at 9:00 am CTCG MedTech, Diagnostics and Digital Health & Services Forum in New York on Thursday, November 21. (1x1 meetings, no webcast)Piper Sandler 36th Annual
Yahoo
As major U.S. indexes experience a downturn, driven by disappointing earnings reports from big tech companies, investors are exploring alternative opportunities in the market. Penny stocks, often representing smaller or newer companies, continue to attract attention despite their vintage label. These stocks can offer surprising value and growth potential when backed by strong financials, making them an intriguing option for those seeking under-the-radar investment opportunities.
Yahoo
Accolade (ACCD) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Yahoo
Accolade, Inc. (Nasdaq: ACCD) today announced that Renalogic, the recognized industry leader that manages the human and financial costs of chronic kidney disease (CKD) for self-insured employers and their members, will join the company's Trusted Partner Ecosystem, to offer its proven CKD risk management and dialysis cost containment solutions.
Yahoo
Accolade ( NASDAQ:ACCD ) Second Quarter 2025 Results Key Financial Results Revenue: US$106.4m (up 9.8% from 2Q 2024...
Yahoo
Accolade Inc (ACCD) surpasses revenue expectations and maintains a robust cash position, while navigating market pressures and strategic challenges.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.